Loading
Chairs NRG Oncology, the largest US radiotherapy cooperative group, and leads head and neck de-escalation trials.
Quynh-Thu Le is group chair of NRG Oncology, which runs the national radiotherapy-based trials in the United States, and has led NRG head and neck studies including HN002 and HN005 on de-escalating radiotherapy for HPV-positive oropharyngeal cancer. Her laboratory studies tumour hypoxia and galectin-1 as targets and biomarkers, and she chairs radiation oncology at Stanford.
Shares Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam) and the tags radiotherapy, head-and-neck.
Shares NRG-HN002 & NRG-HN005 (HPV+ de-escalation), Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
Shares NRG-HN002 & NRG-HN005 (HPV+ de-escalation), Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam).
Shares IMRT / IGRT (modern external beam) and the tags radiotherapy, nrg-oncology.
Shares Head and neck squamous cell carcinoma, IMRT / IGRT (modern external beam) and the tag head-and-neck.
Shares IMRT / IGRT (modern external beam) and the tag radiotherapy.
Shares Head and neck squamous cell carcinoma and the tag radiotherapy.
Shares IMRT / IGRT (modern external beam) and the tag radiotherapy.